211.50 -3.78 (-1.76%)
After hours: 7:55PM EDT
|Bid||212.40 x 800|
|Ask||213.00 x 900|
|Day's range||201.68 - 216.04|
|52-week range||60.05 - 253.00|
|Beta (5Y monthly)||0.30|
|PE ratio (TTM)||N/A|
|Earnings date||28 Oct 2020 - 02 Nov 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||241.46|
Shares of Teladoc Health (NYSE: TDOC) and Livongo Health (NASDAQ: LVGO), two telehealth companies that recently agreed to merge, rose sharply on Tuesday. The stocks' move higher was likely fueled by a combination of an overall bullish trading day for tech stocks and an analyst's decision to initiate coverage of Teladoc stock with a buy rating. D.A. Davidson analyst Hannah Baade initiated coverage of Teladoc with a buy rating and a $250 12-month price target.
One that's standing out like a life raft is GoodRx, a company with a unique business model and several other attributes that are sure to draw a lot of investor attention. Its core product is a price-searching service for prescription medications, which it offers through a dedicated smartphone app. The company is paid a percentage of every sale, hewing to the classic middleman business model.
Teladoc (TDOC) closed the most recent trading day at $202.66, moving -1.35% from the previous trading session.